Metabolic Regulation of Inflammation: Exploring the Potential Benefits of Itaconate in Autoimmune Disorders
Immunology · 2025-02 · 174 (2) · 189-202
DOI: 10.1111/imm.13875 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Immunology, online erschienen am 14.11.2024. Verfasst von Yin Luo und 5 weiteren Autor:innen. Beteiligte Einrichtung: The First Affiliated Hospital, Department of Metabolism and Endocrinology, Hengyang Medical School, University of South China, Hengyang, Hunan, China. Hauptthemen laut MEDLINE: Succinates, Inflammation, Autoimmune Diseases. Die Arbeit wurde bisher 19-mal zitiert (Crossref) und nennt 122 Literaturangaben. Gefördert von: Natural Science Foundation of Hunan Province (2023JJ70054 to Li-yan Jiang), National Natural Science Foundation of China (No. 82070873 to Xin-Hua Xiao), National Natural Science Youth Fund(82000813 to Ya-Di Wang).
Abstract (Originalsprache)
Itaconic acid and its metabolites have demonstrated significant therapeutic potential in various immune diseases. Originating from the tricarboxylic acid cycle in immune cells, itaconic acid can modulate immune responses, diminish inflammation, and combat oxidative stress. Recent research has uncovered multiple mechanisms through which itaconic acid exerts its effects, including the inhibition of inflammatory cytokine production, activation of anti‐inflammatory pathways, and modulation of immune cell function by regulating cellular metabolism. Cellular actions are influenced by the modulation of metabolic pathways, such as inhibiting succinate dehydrogenase (SDH) activity or glycolysis, activation of nuclear‐factor‐E2‐related factor 2 (Nrf2), boosting cellular defences against oxidative stress, and suppression of immune cell inflammation through the NF‐κB pathway. This comprehensive review discusses the initiation, progression, and mechanisms of action of itaconic acid and its metabolites, highlighting their modulatory effects on various immune cell types. Additionally, it examines their involvement in immune disease like rheumatoid arthritis, multiple sclerosis, type 1 diabetes mellitus, and autoimmune hepatitis, offering greater understanding for creating new therapies for these ailments.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- The First Affiliated Hospital, Department of Metabolism and Endocrinology, Hengyang Medical School, University of South China, Hengyang, Hunan, China.
ORCID-Profile: Ya-Di Wang, Xin-Hua Xiao
Förderung
- Natural Science Foundation of Hunan Province (2023JJ70054 to Li-yan Jiang)
- National Natural Science Foundation of China (No. 82070873 to Xin-Hua Xiao)
- National Natural Science Youth Fund(82000813 to Ya-Di Wang)
Zitieren
APA
Luo, Y., Jiang, L. Y., Liao, Z. Z., Wang, Y. Y., Wang, Y. D., & Xiao, X. H. (2025). Metabolic Regulation of Inflammation: Exploring the Potential Benefits of Itaconate in Autoimmune Disorders. Immunology, 174(2), 189-202. https://doi.org/10.1111/imm.13875
Vancouver
Luo Y, Jiang LY, Liao ZZ, Wang YY, Wang YD, Xiao XH. Metabolic Regulation of Inflammation: Exploring the Potential Benefits of Itaconate in Autoimmune Disorders. Immunology. 2025;174(2):189-202. doi:10.1111/imm.13875
BibTeX
@article{Luo2025,
author = {Luo, Yin and Jiang, Li-Yan and Liao, Zhe-Zhen and Wang, Yuan-Yuan and Wang, Ya-Di and Xiao, Xin-Hua},
title = {Metabolic Regulation of Inflammation: Exploring the Potential Benefits of Itaconate in Autoimmune Disorders},
journal = {Immunology},
year = {2025},
volume = {174},
number = {2},
pages = {189--202},
doi = {10.1111/imm.13875}
}
EUVIMED